Therefore, vaccines can be developed to control any of these phases and will be accordingly called
(i) antisporozoite vaccine, which will prevent malaria in the vaccinated individual and also block its spread;
(ii) antimerozoite vaccine which will protect or ameliorate the patient but will not check the spread of the disease and
(iii) antigametocyte vaccine, which would prevent the spread without helping the patient. Of these, antisporozoite vaccine is in sight due to cloning of gene meant for circumsporozoite (CS) protein.
This gene was obtained directly from DNA of erythrocytic form of parasite, rather than as cDNA from mRNA. This cloned gene may, in course of time, lead to the synthesis of vaccine b) synthesizing CS protein by cloned gene.



